Vaniqa is a topical prescription cream aimed at the reduction of unwanted facial hair. Women in particular, although some men apply, spend thousand of dollars every year attempting to reduce or eliminate their facial hair. Considered an unsightly condition, Vaniqa is a welcome relief to the market.
Vaniqa carries a very low risk of side effects. It is not an ingestible formula, thus all side effects tend to be skin related. There may be the rapid development of redness, burning, stinging, dryness, itching, or a tingling sensation at the site of application. These side effects are more likely or likely to increase if the application is applied to an area of previous affected skin or broken skin.
It is possible to experience an allergic reaction to Vaniqa. Though no serious allergic reactions have been reported from its use, mild skin reactions such as acne, blistering, excessive peeling, and painful, sore like rashes have been known to develop in patients with particularly sensitive skin.
A condition called folliculitis may develop in a low percentage of patients. Commonly called hair bumps, they present no danger and are simple unattractive. A patient experiencing the onset of hair bumps should consult with their prescribing physician in order to determine if Vaniqa is appropriate for their use.
The side effects associated with Vaniqa are mild, but can be somewhat uncomfortable to the patient. If this situation arises, limited the application to one time per day and there should be a noticeable reduction in side effect symptoms.
Vaniqa is intended for external use and is not meant for human consumption. The risk of internal ingestion is small. In the case of swallowing, seek immediate poison control assistance. In most cases Vaniqa will cause an upset stomach, diarrhea, or vomiting, but it is still important to check with a doctor about possible unknown side effects or the effects it may or may not have on children.
Should Vaniqa accidentally get into the eyes, the patient should flush they entire eye with water and consult a doctor. There may be an adverse effect on patients with contact lenses. If Vaniqa gets into the nose or mouth, wash the affected area well with water and if any signs of reaction occur, consult with a physician immediately.
It is unknown if Vaniqa has any ill effect on fetuses or on nursing babies. At this time, there are no known effects, though a patient should always consult with a doctor prior to beginning any medication when they are nursing or pregnant.
Cosmetics and sunscreen have no known interaction with the application of Vaniqa. They can generally be applied within several minutes of the application of Vaniqa to the affected areas.
Typically Vaniqa does not interact poorly with any other topical medication. However, individual patients have unique sensitivity levels to skin irritants. It is best to consult a physician prior to adding any other topical solution to the skin.
Vaniqa has been known to have success in reducing the appearance and presence of unwanted hair production. It has helped thousands of women improve their appearance and save countless dollars trying to alleviate this common cosmetic problem.
VANIQA is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine hydrochloride as eflornithine hydrochloride monohydrate (150 mg/g). Chemically, eflornithine hydrochloride is (±) -2-(difluoromethyl) ornithine monohydrochloride monohydrate, with the empirical formula C 6 H 12 F 2 N 2 O 2 ·HCl· H 2 O, a molecular weight of 236.65. Anhydrous eflornithine hydrochloride has an empirical formula C 6 H 12 F 2 N 2 O 2 · HCl and a molecular weight of 218.65. Other ingredients include: ceteareth-20, cetearyl alcohol, dimethicone, glyceryl stearate, methylparaben, mineral oil, PEG-100 stearate, phenoxyethanol, propylparaben, stearyl alcohol and water.
Vaniqa has the following structural formula: